dMed Biopharmaceutical Company Limited is a clinical Contract Research Organization (CRO), providing high-quality end-to-end services to innovative biopharmaceutical and medical device companies in China and globally. dMed offers professionalism, global clinical trial experience, advanced technology and innovative methods to our clients, meeting the standards of health and regulatory authorities. dMed desires to improve clinical development capabilities in China to facilitate globalization of Chinese drug innovators; Innovate to radically improve clinical trial efficiency to increase the probability of success of R&D products.
dMed gathered a large number of professionals, most of them are from global leading biopharmaceutical companies or multinational Contract Research Organizations with global capabilities, extensive working experience in clinical trials. Our core services are Consulting, Clinical Operations, Biostatistics & Programming, Data Management, Drug Safety and Pharmacovigilance, Clinical Sciences and Medical Affairs, Quality Assurance and Audit, Regulatory Affairs and Submission.